BackPharma-Bio Serv Overview
Pharma-Bio Serv, Inc.

Pharma-Bio Serv Return on Equity

Pharma-Bio Serv (PBSV) has a ROE of -0.13%, below the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

-0.13%

Return on Equity

-0.13%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Pharma-Bio Serv (PBSV) FAQ

The latest ROE for PBSV is -0.13%. That is below the sector sector average of 11.3%. Investors often review this figure alongside Pharma-Bio Serv's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, PBSV currently prints -0.13% for ROE, while the sector average sits near 11.3%. That is roughly 101.2% below the sector mean. Large gaps often invite a closer look at Pharma-Bio Serv's growth, margins, and balance sheet.

Return on Equity shows how effectively Pharma-Bio Serv converts resources into returns. At -0.13%, PBSV may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting PBSV's ROE (-0.13%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.